Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the Fidelity MSCI Health Care Index ETF (FHLC), a passively managed exchange traded fund launched on October 21, 2013.

Zacks Investment Research • Nov 4, 2025

Midyear Sector Roundup: AI Enthusiasm Drives Returns

Midyear can be an ideal opportunity for investors to re-evaluate their portfolios and consider rebalancing to align with their ideal asset allocation. As the midpoint of 2025 passes, the U.S. stock market has delivered a mixed bag of performance across sectors, driven largely by continued enthusiasm for artificial intelligence (AI) and fluctuating economic conditions.

ETF Trends • Aug 20, 2025

FHLC: An Average Healthcare ETF

FHLC is a solid healthcare ETF, but VHT offers slightly better performance, liquidity, and diversification for a similar expense ratio. FHLC's high concentration in top holdings and lower trading volume raise concerns compared to VHT's broader portfolio and superior liquidity. Healthcare sector tailwinds like innovation, aging demographics, and biotech growth benefit all major ETFs, but VHT stands out on key metrics.

Seeking Alpha • Jul 11, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Seeking Alpha • May 30, 2025

FHLC: Poised To Capture Strong Healthcare Demand And Growth

Fidelity MSCI Health Care Index ETF is a buy due to its strong healthcare holdings, low fees, and solid performance track record. FHLC offers diversification with 368 U.S. large-cap holdings, outperforming peer funds with a 10-year CAGR of 9.32% and an expense ratio of 0.08%. Top holdings like Eli Lilly, UnitedHealth Group, and Johnson & Johnson are poised for future growth, enhancing FHLC's potential for long-term gains.

Seeking Alpha • Mar 4, 2025

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seeking Alpha • Feb 25, 2025

Fidelity Crosses $100 Billion ETF Milestone

In mid-November, Fidelity Investments joined the select ‘$100 billion in ETF assets' club. While the firm still has a sizable presence in the mutual fund world, Fidelity's ETFs have been gaining traction in 2024.

ETF Trends • Nov 21, 2024

What Lies in Store for Healthcare ETFs in Q3 Earnings?

Big stocks are likely to dominate the returns of the healthcare ETF going into Q3 earnings announcements.

Zacks Investment Research • Oct 25, 2024

FHLC ETF: Play Defensive For 2 Reasons

The Fidelity MSCI Healthcare Index ETF offers diversified exposure to healthcare, with a lower expense ratio and better performance than the Healthcare Select Sector SPDR Fund ETF. Economic uncertainty favors defensive sectors like healthcare, which is also expected to outperform IT in earnings growth for 2024. Despite potential short-term volatility, FHLC's defensive holdings, superior liquidity risk, and dividend grades make it a prudent buy, with a P/E ratio below the sector average.

Seeking Alpha • Sep 29, 2024